Middle East Pharmaceutical Industries Company Stock Price

SASE:4016 Community·ر.س2.3b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
10 Fair Values set on narratives written by author

Create a narrative

4016 Share Price Performance

ر.س0

-120.20 (-100.00%)

ر.س0

-120.20 (-100.00%)

ر.س0

Thu, 18 Dec 25

Share Pricen/a

4016 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Outstanding track record with excellent balance sheet.

0 Risks

2 Rewards

View Full Analysis

Middle East Pharmaceutical Industries Company Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 4.86
: 61.97%
: 21.20%
: 16.8%

View Full Analysis

About 4016

Founded: 1998
Employees: 632
CEO: Mohammed Maher Al-Ghannam
WebsiteView website: www.avalonpharmaceutical.com

Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. Its product portfolio includes dermatological, respiratory, cardiovascular, alimentary and anti-infectives, musculoskeletal, genitourinary systems, and CNS. The company also exports its products. Middle East Pharmaceutical Industries Company was formerly known as Middle East Chemical Products Factory Company and changed its name to Middle East Pharmaceutical Industries Company in January 2006. Middle East Pharmaceutical Industries Company was incorporated in 1998 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.